A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...

My Happy Marriage was hit with a delay for the final episode of the season that was scheduled to make its debut as part of the Winter 2025 anime schedule, but it has now premiered in Japan.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment, according to findings from a study published in JAMA Neurology.

GLP-1 weight-loss medications lead to reduced consumption of processed foods, soda, refined grains, beef, starchy vegetables, pork, alcohol, fruit juice, and dairy milk. Despite these reductions ...

Scientists at the Arkansas Agricultural Experiment Station led the study, a survey of past, current, and potentially future GLP-1 users. They found that people were most likely to reduce their ...

GLP-1RA versus other second-line glucose-lowering drugs SGLT2i versus other second-line glucose-lowering drugs GLP-1RA versus SGLT2i. The scientists concluded that GLP-1RAs and SGLT2is were ...

These included GLP-1 receptor agonists like Ozempic (which promote insulin production and feelings of fullness); SGLT2 inhibitors (which prevent the kidneys from reabsorbing glucose, forcing its ...